… further the efficacy and tolerability of 6.25- and 12.5-mg doses of almotriptan compared with
… three consecutive migraine attacks and to analyse the consistency of the therapeutic effect. …

… 12.5 mg in this study was consistent overall with previous experience with almotriptan. …
consistent with short-term placebo-controlled studies where almotriptan 12.5 mg had a tolerability …

… Almotriptan maintains a consistency of response across three attacks and patients continue
to respond to almotriptan … that almotriptan 12.5 mg demonstrates comparable efficacy with …

… However, almotriptan 12.5 mg had a tolerability profile … assess the long-term tolerability and
safety of oral almotriptan 12.5 mg … evaluate efficacy in this setting, particularly the consistency …

… assessed efficacy, tolerability, and satisfaction with almotriptan 12.5 … study are consistent
with those from a study in which … period) were randomized to almotriptan 12.5 mg or placebo. In …

… with almotriptan 6.25 mg, 12.5 mg, 25 mg, or placebo. The primary efficacy endpoint was …
The 2‐hour pain‐relief rate was significantly higher with almotriptan 25 mg compared with …

… 6 Pascual J, Falk RM, Piessens F, Prusinski A, Docekal P, Robert M, Ferrer P, Luria X,
Segarra R, Zayas JM: Consistent efficacy and tolerability of almotriptan in the acute treatment of …

… efficacy and safety of almotriptan in the treatment of acute migraine. A meta-analysis of 53
RCTs comparing efficacy, tolerability, and consistency … mg found that almotriptan 12.5 mg was …

… Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine
attacks: results of a large, randomized, double-blind, placebo-controlled study. Cephalalgia …

… with regard to efficacy, tolerability and consistency of treatment … Almotriptan is a newer triptan
shown to be consistently … for establishing the efficacy and tolerability profile of almotriptan, …